ArticleNeuro-oncology advances

Increased immunogenicity of hypermutated SB28 syngeneic glioblastoma is partially mediated by alterations in tumor chemokine expression.

Kevin Thomas Breen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.